Faheem Hasnain compensation by year
Gossamer Bio Summary Compensation Table · all 8 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Salary | $469,601 | $199,896 | $71,500 | $574,350 | $591,637 | $606,901 | $628,173 | $649,649 |
| Bonus | $297,700 | $99,750 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $17,942,611 | $0 | $0 | $1,590,875 | $0 | $0 | $0 | $0 |
| Option awards | $0 | $619,945 | $396,591 | $2,265,185 | $6,359,885 | $1,185,725 | $1,043,438 | $1,392,006 |
| Non-equity incentive | $0 | $0 | $54,300 | $321,210 | $310,888 | $303,362 | $329,822 | $254,800 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $62,631 | $76,380 | $0 | $0 | $0 | $4,000 | $4,000 |
| Total | $18,709,911 | $982,222 | $598,771 | $4,751,620 | $7,262,410 | $2,095,988 | $2,005,432 | $2,300,455 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Gossamer Bio, Inc. DEF 14A filed April 24, 2026, accession 0001728117-26-000027, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Gossamer Bio, Inc. filed document, accession 0001728117-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 437,500 | $1,356,250 | — |
| Option | 683,594 | — | $0.97 |
| Option | 1,540,000 | — | $1.13 |
| Option | 209,636 | — | $0.84 |
| Option | 170,157 | — | $1.21 |
| Option | 750,000 | — | $1.36 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Gossamer Bio, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed April 24, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-24 | Grant or award derivative | — | 166 | $1000.00 | 166 |
| 2026-08-24 | Grant or award derivative | — | 5,800,051 | $0.00 | 5,800,051 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Gossamer Bio discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $653,331 | $6,139,057 | — | — |
| Resignation for good reason, no change in control | $653,331 | $6,139,057 | — | — |
| Death | $0 | — | $0 | — |
| Change in control and involuntary termination | $979,997 | $7,495,307 | — | — |
| Change in control and resignation for good reason | $979,997 | $7,495,307 | — | — |
| Disability | $0 | — | $0 | — |
Per the Potential Payments Upon Termination or Change in Control table in Gossamer Bio, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Gossamer Bio’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Faheem Hasnain · this page | Chairman, President and Chief Executive Officer | $2,300,455 |
| Bryan Giraudo | Chief Operating Officer and Chief Financial Officer | $1,253,431 |
| Robert Smith | Chief Commercial Officer | $1,180,744 |
Board service
Gossamer Bio board · FY2021–FY2025How this board is paid
Company policy: Gossamer Bio pays directors a $40,000 cash retainer. As stated in Gossamer Bio's FY2025 proxy.
The full Gossamer Bio compensation record
free company briefThis page is one person within Gossamer Bio's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Gossamer Bio proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Gossamer Bio's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Gossamer Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order GOSS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.